INVENTIVA: Combined General Meeting of May 25, 2023. Availability of the preparatory documents

Daix (France), Long Island City (New York, United States), May 4, 2023 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small

Related Keywords

Le Jura ,France General ,France ,Brunswick ,Niedersachsen ,Germany ,Ukraine ,United States ,Russia ,Daix ,Bourgogne ,New York ,French ,Aude Lepreux ,Pascaline Clerc ,Patricial Bank ,Brunswick Group ,Global External Affairs ,Nasdaq ,Exchange Commission On ,Long Island City ,Euronext Paris ,Combined General Meeting ,Oceania Le Jura ,Exchange Commission ,French Commercial Code ,Rue De Dijon ,Combined General ,General Meeting ,Global External ,Roquet Montegon ,Private Securities Litigation Reform Act ,New Drug Application ,Universal Registration Document ,Des March ,Annual Report ,Inventiva ,Combined ,Eneral ,Meeting ,023 ,Availability ,Preparatory ,Documents ,